Atlas Trials

Dose Response Study of a Topical Formulation of Nitroglycerin for the Treatment of Raynaud's Phenomenon

Clinical trial NCT00480753 · COMPLETED

Trial details

NCT number
NCT00480753
Sponsor
MediQuest Therapeutics
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Raynaud's Disease
Start date
2007-05-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.